Literature DB >> 716907

Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.

P J Klemi.   

Abstract

The presence of argyrophil and argentaffin cells and epithelial mucosubstances was studied in 187 mucinous ovarian cystadenomas of varying malignancy. Sixty-two per cent of the benign tumours contained these cells. The corresponding figures for tumours of borderline malignancy and malignant tumours were 60 and 51, respectively. The epithelial cells of the mucinous cystadenomas characteristically contained periodic acid-Schiff reactive and diastase resistant secretory material, mixed with acid mucin which contained both sulphate and carboxyl groups. The amount of mucin diminished with increasing malignancy, as did the ratio of neutral to acid mucins. Mucin histochemistry in tumours with and without argyrophil cells in a given group of malignancy was similar, and the ages of the patients having those tumours did not differ significantly.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 716907

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  4 in total

1.  Neurohormonal peptide immunoreactive cells in mucinous cystadenomas and cystadenocarcinomas of the ovary.

Authors:  B Sporrong; J Alumets; L Clase; S Falkmer; R Håkanson; O Ljungberg; F Sundler
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

2.  Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.

Authors:  Jerome T O'Connell; James S Tomlinson; Alice A Roberts; Kathryn F McGonigle; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  O-acylated sialic acid variants in mucinous tumours of the ovary.

Authors:  G Lapertosa; P Baracchini; E Fulcheri; R Tanzi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Endocrine cell micronests in an ovarian mucinous borderline tumor: a potential diagnostic pitfall for microinvasion.

Authors:  Katrina Collins; Sheila Segura; Michael Hwang
Journal:  Diagn Pathol       Date:  2022-04-14       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.